Role of CA2+/calmodulin on ethanol neurobehavioral effects by González Aragón, Carlos Manuel et al.
ORIGINAL INVESTIGATION
Role of CA2+/calmodulin on ethanol neurobehavioral effects
Pablo Baliño & Juan Carlos Ledesma &
Carlos M. G. Aragon
Received: 24 August 2013 /Accepted: 29 April 2014 /Published online: 23 May 2014
# Springer-Verlag Berlin Heidelberg 2014
Abstract
Rationale The cAMP-dependent protein kinase A (PKA) sig-
naling transduction pathway has been shown to play an im-
portant role in the modulation of several ethanol-induced
behaviors. Different studies have demonstrated intracellular
calcium (Ca2+)-dependent activation of the PKA cascade after
ethanol administration. Thus, the cAMP cascade mediator
Ca2+-dependent calmodulin (CaM) has been strongly impli-
cated in the central effects of ethanol.
Objectives In this study, we assessed the role of the CaM
inhibitor W7 on ethanol-induced stimulation, ethanol intake,
and ethanol-induced activation of PKA.
Methods Swiss mice were pretreated with W7 (0–10 mg/kg)
30 min before ethanol (0–3.75 g/kg) administration.
Immediately, animals were placed during 20 min in an
open-field chamber. Ethanol (10 %, v/v) intake in 2 h was
assessed using a limited access paradigm. Experiments with
caffeine (0–15 mg/kg), cocaine (0–4 mg/kg), and saccharine
(0.1 %, w/v) were designed to compare their results to those
obtained with ethanol. Western blot was assayed 45 min after
ethanol administration.
Results Results showed that pretreatment with W7, reduced
selectively in a dose-dependent fashion ethanol-induced loco-
motor stimulation and ethanol intake. The ethanol-induced
activation of PKAwas also prevented by W7 administration.
Conclusions These results demonstrate that CaM inhibition
resulted in a selective reduction of ethanol-stimulating effects
and ethanol intake. The PKA activation induced by ethanol
was blocked after the CaM blockade with W7. These results
provide further evidence of the key role of cellular Ca2+-
dependent pathways on the central effects of ethanol.
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Introduction
Alcohol exerts a wide range of effects through its interaction
with several neurotransmitters and neuromodulators in the
CNS. Behavioral consequences observed after ethanol admin-
istration have been well characterized; however, the molecular
mechanisms by which ethanol alters cellular function and how
some of these alterations translate to changes in behavior are
still unclear. To date, research has failed to identify a unique
mechanism of action for alcohol in the CNS. The cAMP
signaling pathway has emerged as an important modulator
of ethanol sensitivity. Thus, in vivo, it has been demonstrated
that manipulations of the cAMP signaling, affected different
behavioral responses elicited by ethanol (Lee and Messing
2008; Maas et al. 2005; Wand et al. 2001). Recent published
data from our laboratory demonstrated intracellular calcium
(Ca2+)-dependent activation of the cAMP-dependent protein
kinase (PKA) cascade after ethanol administration (Baliño
et al. 2013). At this respect, the PKA signaling transduction
pathway has been shown to play an important role in the
modulation of several ethanol-induced behavioral actions.
Manipulations involving the cAMP/PKA pathway modulate
the ethanol-induced locomotor activity and sensitization
(Freund and Palmer 1997; Hayes et al. 2012; Tolliver et al.
1999), ethanol sensitivity (Thiele et al. 2000; Wand et al.
2001), and ethanol intake (Pandey et al. 2005).
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The cAMP synthesis is determined by the activity of the
adenylyl cyclases (AC), which convert ATP to cAMP.
Different AC subtypes have been found to be highly
expressed in the mammal brain and have also been suggested
as critical mediators of the cAMP/PKA cascade (Conti et al.
2009). Among others, it has been shown that AC1 and AC8
play a critical role in mediating the cAMP-dependent signal
transduction in response to ethanol (Conti et al. 2009; Maas
et al. 2005; Wand et al. 2001). Moreover, AC1 and AC8 are
directly stimulated by Ca2+ via calmodulin (CaM) activation
(Cali et al. 1994; Wang et al. 2003).
CaM has been described as one of the key proteins on
transducing a signal in response to intracellular Ca2+increase.
It serves as a ubiquitous intracellular Ca2+receptor (Chin and
Means 2000) and is expressed in all eukaryotic cells where it
participates in different signaling pathways that regulate many
crucial cellular processes. CaM is a 148-amino acid protein
(16,680 daltons) that comprised four helix–loop–helix protein
folding motifs called EF hands, with two making up the N-
terminal domain and two comprising the C-terminal domain.
Upon calcium binding, CaM activates members of a family of
serine/treonine protein kinases called Ca2+/CaM-dependent
protein kinases such as CaM kinases I, II, and IV and myosin
light-chain kinase (Hook andMeans 2001). These kinases have
been involved in many aspects of neuronal function, including
synaptic plasticity, gene expression, and neurotransmitter syn-
thesis and release. Furthermore, Ca2+/CaM kinases have been
described as an important molecular mechanism involved in the
neurobiological response to drug abuse (Jackson et al. 2012;
Robison et al. 2013). At this respect, different Ca2+/CaM ki-
nases such CaM kinase II, have been described to play a key
role on the behavioral response to ethanol in a rodent model
(Easton et al. 2013; Wang et al. 2012). However, the particular
mechanism by which ethanol modulates the activity of the
Ca2+/CaM kinases has not been clarified in detail yet.
Interestingly, ethanol administration has proved to modu-
late Ca2+distribution and flux in different neuronal cell prep-
arations (Cofán et al. 2000; De Beun et al. 1996). In addition,
acute exposure to ethanol increases intracellular Ca2+in a
dose-dependent manner when administered at concentrations
(<80 mM) and decreases at greater concentrations (>120 mM)
(Belia et al. 1995). In fact, studies using brain synaptosomes
and cultures of rat hippocampal neurons showed that an acute
administration of ethanol produced an increase in intracellular
Ca2+, including medium solutions containing zero Ca2+, as a
result of its release from internal stores (Daniell and Harris
1989; Mironov and Hermann 1996).
Given this, the aim of the present investigation was to
evaluate the role of Ca2+/CaM on ethanol-induced stimulation
and ethanol intake. Thus, we have selected the CaM blocker
W7. This compound binds with high affinity to CaM in the
presence of Ca2+, and thereby blocks access to the activation
site exposed when the Ca2+-binding sites in CaM are occupied
(Osawa et al. 1998; Qu et al. 2007). We hypothesized that the
CaM blockade by the W7 agent would decrease the
cAMP/PKA pathway activity and therefore ethanol-induced
stimulation and ethanol intake. The aims of this investigation
were also extended to study whether this pharmacological tool
is selective in reducing ethanol-stimulating effects or ethanol
intake when compared with other drugs with motor-
stimulating properties and to a sweetened solution. The results
derived from the present work would support a new ethanol
mechanism of action at a central level that involves intracel-
lular Ca2+ release to further activate a cAMP/PKA-dependent
cascade through a CaM-dependent mechanism.
Materials and methods
Animal husbandry
Naive male Swiss (CD-I) mice, purchased from Elevage
Janvier (Saint-Genest, France) were used in this study. Mice
aged 4 weeks upon arrival at our laboratory were housed
(three per cage) and acclimated to the colony room at least
2 weeks prior to the initiation of the study. Room temperature
was maintained at 22±1 °C and humidity (50 %) in a 12/12-h
light–dark cycle (lights on at 8 a.m.). Animals had free access
to rodent chow (Panlab, Barcelona, Spain) and tap water.
Swiss CD-I mice used in this study were chosen for its steady
response to the stimulating and hypnotic effects of ethanol
(Correa et al. 2001; Pastor et al. 2002). This CD-I mice strain
was also used for the immunoblot analysis. For the ethanol
intake experiment, 16 male C57BL/6 J (B6) mice (this JAX®
mice strain was purchased from Charles River Laboratories
España S.A., Barcelona) per group aged 6–8 weeks were used.
Mice were housed four per cage for the first 2 weeks, and then
transferred to individual cages for 1 week prior to the begin-
ning of the experiment. Animals had free access to rodent
chow (Panlab, Barcelona, Spain) and tap water. Room tem-
perature was maintained at 22±1 °C and humidity (50 %) in a
12/12-h light–dark cycle (lights off at 7 a.m.). Red incandes-
cent lamps were kept on during the dark phase so that inves-
tigators could handlemice. This strain of mice was used in this
study because of their genetic background of high ethanol
preference (McLearn and Rodgers 1959; Rhodes et al. 2005).
All experimental procedures complied with the European
Community Council Directive (86/609/ECC).
Drugs and drinking solutions
Ethanol (Panreac, Barcelona, Spain) stocked at 96 % in a glass
container, was diluted to 20 % (v/v) in 0.9 % (w/v) physiolog-
ical saline for the injections (saline solution was administered
to control groups). Ethanol (2–10 %, v/v) and saccharine
(0.1 %, w/v) for drinking solution was diluted to the appropriate
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concentration in tap water. N-(6-Aminohexyl)-5-chloro-1-
naphthalenesulfonamide hydrochloride (W7), caffeine, and co-
caine were purchased from Sigma-Aldrich Química (Madrid,
Spain); all doses of these compounds (see “Procedure”) were
diluted in 0.9 % physiological saline in an injection volume of
10 ml/kg. All solutions were administered intraperitoneally
(i.p.) and prepared fresh daily in saline.
Procedure
Locomotor stimulation induced by ethanol
Seven different independent experimental phases were con-
ducted to assess the effects of CaM blockade with W7 on
ethanol neurobehavioral effects in mice. Animals (n=12–15)
were moved from their home cages to the locomotor activity
testing room at least 30 min before experiment initiation to
allow acclimation to environmental conditions. Testing oc-
curred between 10 a.m. and 4 p.m. Experiment 1 assessed
the effect of W7 (0, 1.25, 2.5, 5, and 10 mg/kg, i.p.) on
ethanol-induced locomotor activity. These doses were used
in accordance with previous published work (Barron et al.
1986; Ito 1986). Moreover, there is evidence suggesting that
W7 can be administered systemically at doses (0–10 mg/kg)
that would have no effect on mice spontaneous behavior and
has direct CNS actions (Barron et al. 1986; Ito 1986; Osawa
et al. 1998). Mice (n=12–15) were injected with saline or one
of the four doses of W7 and returned to their home cages for a
waiting period of 30 min. After this time, a challenge dose of
ethanol (0 or 2.5 g/kg, i.p.) was administered immediately
prior to placing animals in the open field, where horizontal
activity was measured for 20 min. Experiment 2 studied the
effects of several ethanol doses (0, 1.25, 2.5, and 3.75 g/kg,
i.p.) on locomotion in animals (n=12–15) pretreated with W7
(0 or 5 mg/kg, i.p.). This ethanol dose range was designed to
evaluate the W7 role from the stimulant-to-sedative effects of
ethanol (Pastor et al. 2002; Pohorecky 1977). Experiment 3
was conducted to explore the temporal pattern of the effect of
W7 on ethanol-induced stimulation. Animals (n=12–15) were
pretreated with W7 (0 or 5 mg/kg, i.p.) 15, 30, or 60 min
before ethanol (2.5 g/kg, i.p.). Experiment 4 explored the
effects of W7 on locomotor stimulation induced by the fol-
lowing drugs: caffeine and cocaine. Here, we have evaluated
whether the effects of W7 found in previous experimental
phases on ethanol stimulation are shared by other drugs with
psychomotor properties. Mice (n=10–12) were injected with
W7 (0, 2.5, 5, and 10 mg/kg, i.p.) 30 min before caffeine
(15 mg/kg, i.p.) or cocaine (4 mg/kg, i.p.) administration.
Animals were placed immediately in the open field for
20 min to measure the locomotor activity. Doses of caffeine
and cocaine were selected in accordance with previous studies
that have demonstrated a locomotor activity increase on in our
experimental conditions (Font et al. 2001; Pastor et al. 2002).
Ethanol intake
The methodology followed in the drinking procedures corre-
sponds to a limited-access paradigm. Briefly, alcohol was
always presented at the beginning of the third hour of the
animals’ dark cycle (at 10 a.m.). Prior to the initiation of the
experiments, mice were subjected to a habituation period.
Every 2 days, mice received escalating ethanol concentra-
tions, from 2 to 10 % (v/v) during ten consecutive days. This
period of habituation to ethanol drinking has previously been
used by other authors and serves to accustom animals to the
smell and flavor of ethanol (Wise 1973, 1975). It also avoids
the neophobia initially induced by the presentation of new
fluids in rodents (Aragon and Amit 1993; Correa et al. 2004;
Font et al. 2001). During ethanol presentation, the water
bottles were replaced with 10ml graduated cylinders contain-
ing an ethanol solution for 2 h. When a 10 % concentration of
ethanol was achieved, the baseline phase started, which con-
sists in presenting a 10 % (v/v) solution until the intake of all
mice reached stable levels during at least 5 days. Following
this habituation period, four 2-day test sessions were conduct-
ed. In accordance with a within-subjects design, these sessions
were repeated twice a week for 2 weeks. Experiment 5
assessed the effects of several doses of W7 on ethanol intake.
On the first test day, all mice (n=16) received saline injections
prior (30 min) to alcohol presentation. On the second day of
each 2-day session, each mouse received either an i.p. injec-
tion of saline or 1.25, 2.5, or 5 mg/kg of W7 at the same time
interval as on the preceding day (30 min before water bottles
were replaced for 2 h with ethanol). The order in which the
four doses of W7 were administered was counterbalanced
across animals and days. In experiment 6, we have evaluated
the effect of our pharmacological manipulations on voluntary
saccharin intake. The same experimental design was repeated
with a new cohort of animals (n=16), with the exception that
in this case, no habituation period was needed to obtain stable
saccharin (0.1 %, w/v) intake levels. The volume (ml) of
ethanol or saccharine consumed were recorded 30 min each
during 2 h. Ethanol consumed was later translated into grams
per kilogram.
Determination of blood ethanol levels
To study whether the CaM blocker W7 used in the present
experiments altered blood ethanol levels at the time of testing,
a separate experiment with no behavioral testing involved was
conducted. Experiment 7 evaluated the ethanol pharmacoki-
netic response toW7. Animals (n=6) were pretreatedwithW7
(0 or 5 mg/kg, i.p.) 30 min before ethanol treatment (2.5 g/kg,
i.p.). Tail-vein blood samples (20 μl) were collected 10, 20,
60, and 120 min after ethanol administration. Each blood
sample was immediately placed in a microcentrifuge tube
containing 50 μl of ice-cold 5 % ZnSO4 solution. A 50-μl
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aliquot of 0.3 N Ba(OH)2 and 300 μl of deionized water were
added. After centrifugation at 4 °C (5 min, 12,000 rpm), the
supernatant was removed and blood ethanol levels were de-
termined using headspace gas chromatography (CE
Instruments GC 8000, HS 850) (Boehm et al. 2000).
Protein immunoblot analysis
Experiment 8 evaluated the effects of W7 administration on
ethanol-induced PKA activity in different brain areas. Animals
(n=5–10) were pretreated with W7 (0 or 5 mg/kg, i.p.) 30 min
before an ethanol challenge (0 and 2.5 g/kg, i.p.). The neuro-
anatomical dissections were performed 45 min after the etha-
nol administration. The Western blot analyses were performed
following the protocol described byMaas et al. (2005). Briefly,
brains were homogenized in a buffer containing (1 % Nonidet
P-40, 20 mM Tris-HCl (pH 8), 130 mM sodium chloride,
10 mM sodium fluoride, 10 μg/ml aprotinin, 10 μg/ml
leupeptin, 10 mM DTT, 1 mM Na3VO4, and 1 mM PMSF),
and then boiled for 5 min. The protein concentration was
determined using Bradford protein assay. Proteins were sepa-
rated by SDS-PAGE gels and transferred to polyvinylidene
difluoride membranes using standard techniques. Membranes
were blocked with 5 % BSA in Tri-buffered saline and Tween
20 (TBST), and then incubated overnight with anti-
phosphorylated PKA substrate motif, 1:6,000 (Cell Signaling
Technology, Beverly, MA). After washing with TBST, blots
were incubated with HRP-conjugated secondary Ab anti-rabbit
(1/20,000). Blots were developed using the ECL system (ECL
Plus; Amersham Biosciences), and the intensities of the bands
were quantified with SigmaGel image analysis software ver-
sion 1.0 (Jandel Scientific, Madrid, Spain). All samples were
run in duplicate, and band intensities were normalized to saline
controls.
Statistical analyses
For all locomotor activity experiments, horizontal distance
traveled in centimeters in 20 min served as the dependent
variable. Intake experiments evaluated the ethanol (g/kg)
and saccharine (ml) consumed in 2 h as a dependent variable.
Blood ethanol levels were measured as mg/ml. For the
Western blot experiments, the band intensity values were
averaged to obtain a single value for each subject, and then
divided by the GAPDH loading control band intensity. The
average of these normalized values in the saline-treated group
was arbitrarily considered to be 100 %, and then used for
calculations involving all the different experimental manipu-
lations. One- or two-way analysis of variance (ANOVA) and
post hoc comparisons with the Newman–Keuls test were used
when appropriate. Statistical analyses were performed using
Statistica 6.1 (StatSoft, Tulsa, OK) software package.
Results
Experiments 1 and 2: effects of W7 on ethanol-induced
locomotor activity
Figure 1a reflects the effect of W7 on ethanol-induced behav-
ioral stimulation. A significant main effect of the W7 pretreat-
ment dose (F(4, 88)=6.8; p<0.01) was revealed by a two-way
ANOVA. Mean comparisons based on a significant W7 pre-
treatment×ethanol treatment interaction (F(4, 88)=3.26;
Fig. 1 Effect of different doses of W7 on ethanol-induced locomotor
activity. a Animals (n=12–15) were acutely pretreated with W7 (0, 1.25,
2.5, 5, and 10 mg/kg, i.p.) 30 min before ethanol (0 or 2.5 g/kg, i.p.).
Locomotor activity was recorded for 20 min immediately after ethanol
challenge. Shown results are expressed as mean±SEM. #p<0.01, sig-
nificantly different from saline–saline pretreated group; **p<0.01, sig-
nificantly different from saline–ethanol pretreated group. S saline, E
ethanol. b Effect of different doses of ethanol in W7-pretreated animals
(n=12–15). Mice were pretreated with W7 (0 and 5 mg/kg, i.p.) 30 min
before ethanol injection (0, 1.25, 2.5, and 3.75 g/kg, i.p.), and locomo-
tor activity was recorded for 20 min. Results are expressed as mean±
SEM. ##p<0.01, significantly different from saline–saline-treated group;
**p<0.01, significantly different from its respective saline-treated
group. S saline, W7 W7
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p<0.01) revealed that W7 reduced the ethanol-induced stim-
ulation. Newman–Keuls post hoc comparisons among
ethanol-treated groups showed significant differences at the
doses of 1.25, 2.5, 5, and 10 mg/kg (p<0.01) when compared
with the saline–ethanol group. The W7 pretreatment did not
affect locomotor responses after saline treatment. Figure 1b
shows the effect ofW7 (5mg/kg, i.p.) on the locomotor effects
induced by different doses of ethanol (0, 1.25, 2.5, and
3.75 g/kg, i.p.). Results of a two-way ANOVA showed a
significant effect of ethanol dose (F(3, 65)=52.76; p<0.01)
as well as the W7 pretreatment dose (F(1, 65)=16.56;
p<0.01). A significant W7 pretreatment dose×ethanol treat-
ment dose interaction was obtained (F(3, 65)=11.92;
p<0.01). Post hoc Newman–Keuls comparisons among
groups pretreated with saline showed significant differences
between locomotion scores induced by 1.25, 2.5, or 3.75 g/kg
(p<0.01) and those measured after saline treatment. Follow-
up analyses also showed significant differences between
saline- and W7-pretreated groups when ethanol was adminis-
tered at a dose of 2.5 g/kg (p<0.01). No effects of this
compound were found in animals treated with saline or etha-
nol at 1.25 or 3.75 g/kg.
Experiment 3: time course pattern of W7 effects
on ethanol-induced stimulation
Figure 2 shows the time-course effect between W7 (5 mg/kg)
pretreatment and ethanol (2.5 g/kg) treatment groups. Two-
way ANOVA (pretreatment×time) demonstrated a significant
main effect for the pretreatment (F(1, 59)=11.33; p<0.01) as
well as the time factor (F(2, 59)=4.39; p<0.05). A significant
interaction between both factors (pretreatment×time) was
found (F(2, 59)=8.66; p<0.05). Newman–Keuls post hoc com-
parisons indicated that W7 was effective in reducing ethanol-
stimulating effects at 15 and 30 min after pretreatment.
Experiment 4: effects of W7 on locomotor stimulation
produced by other stimulant drugs
Figure 3 shows the effects ofW7 (5mg/kg) on cocaine- (4mg/
kg) and caffeine-induced (15 mg/kg) locomotor stimulations.
Treatment with caffeine (A) (F(1, 45)=43.4; p<0.01) and
cocaine (B) (F(1, 40)=97.4; p<0.01) produced significant
increases in locomotor activity. No significant effect of W7
pretreatment was found either caffeine or cocaine.
Experiments 5 and 6: effect of several doses of W7
on voluntary ethanol and saccharine intake
Figure 4a shows the consequence of W7 administration
(0, 2.5, 5, or 10 mg/kg, i.p.) on ethanol (10 %, v/v) consump-
tion. Results from a one-way ANOVA indicated a significant
effect of the W7 dose (F(3, 44)=34.32; p < 0.01). Post hoc
Newman–Keuls comparisons revealed thatW7 administration
reduced ethanol intake in a dose-dependent manner for all the
doses of the study (p < 0.01). As can be seen in Fig. 4b, W7
(5 or 10 mg/kg, i.p.) had no effect on voluntary saccharin
intake. This conclusion was confirmed by a one-way ANOVA
(F(2, 45)=0.42; p > 0.05).
Experiment 7: effects of W7 on blood ethanol levels
As can be seen in Fig. 5, pretreatment with 5 mg/kg ofW7 did
not modify blood ethanol levels at the time of the behavioral
testing. No significant differences were found (repeated mea-
sures two-way ANOVA; pretreatment×time) for the pretreat-
ment (W7) or the interaction pretreatment×time.
Experiment 8: effect of W7 administration in vivo
on ethanol-induced activated PKA footprint
Figure 6 shows the result of CaM inhibition with W7 on
ethanol-induced PKA footprint in different brain areas.
Results from a two-way ANOVA indicated a significant effect
of the W7 pretreatment in the hypothalamus (B) and striatum
(D) (F(1, 24)=13.6; p<0.01) and (F(1, 18)=7.3; p <0.01),
respectively. Moreover, an ethanol treatment factor effect was
found for the cortex (A) and hippocampus (C) (F(1, 22)=5.6,
p<0.05) and (F(1, 25)=18.6; p<0.01), respectively. Although
a lack of effect of W7 pretreatment or ethanol treatment
was found in some structures of the study, a significant
interaction was obtained between factors in all the neuro-
anatomical areas of the study (F(1, 22)=4.7; p<0.05) cor-
tex, (F(1, 24)=9.6, p<0.01) hypothalamus, (F(1, 25)=9.2;
p<0.01) hippocampus, and (F(1, 18)=12.1; p<0.01) striatum.
Fig. 2 Time course effect of pretreatment with W7 on ethanol-induced
locomotor activity. Mice (n=12–15) were pretreated withW7 (0 or 5 mg/kg,
i.p.) 15, 30, or 60min before ethanol challenge (2.5 g/kg, i.p.), and locomotor
activity was registered. Values represent mean distance traveled (cm)±SEM
for all treatment groups. *p<0.05; **p<0.01, significantly different from its
respective control group. S saline,W7W7
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Post hoc Newman–Keuls comparisons among groups
pretreated with saline showed significant differences after
ethanol injection when compared with its saline control for
all the structures of the study, **p<0.01 and p<0.05.
Significant differences were found among saline–ethanol-
treated groups and W7–ethanol-treated groups for all the
structures of the study. ##p<0.01 and #p<0.05. Furthermore,
no significant differences were found among groups treated
with W7 when compared with its respective control.
Discussion
The present study investigated the effects of CaM inhibition
with W7 on ethanol-induced stimulation, ethanol intake, and
ethanol-dependent PKA footprint. CaM blockade resulted in a
reduction of ethanol-activating effects in a W7 dose-dependent
manner. Doses of W7 that blocked the locomotor activation
produced by ethanol did not modify the spontaneous locomo-
tion of mice. Moreover, the suppression of the motor activity
produced by high doses of this alcohol (Fig. 1b) was not
affected by the pretreatment with W7. This would indicate that
CaM blockade (at doses that reduced ethanol stimulation) had
no effect on the motor-incoordinating, ataxic actions of ethanol
(ethanol sedative effects). At this point, it is worth mentioning
that in our conditions the W7 interaction with ethanol at a high
dose is very near to the floor. Given this, an alternative inter-
pretation of our results would involve a synergistic effect
between ethanol at this dose (3.75 g/kg) and W7. We have
not considered this possibility, as previous published results of
our laboratory involving manipulations of the same proposed
pathway did not increase ethanol sedative effects when
Fig. 3 Effects of W7 on the psychostimulant actions of caffeine (a) and
cocaine (b). Animals (n=12) were pretreated with W7 (0, 2.5, 5, and
10 mg/kg, i.p.), and 30 min later, caffeine (15 mg/kg, i.p.) or cocaine
(4 mg/kg, i.p.) was administered. Treatment with caffeine and cocaine
produced significant increases in locomotor activity. Results expressed as
mean±SEM. **p<0.01 significantly different from its respective saline
group. S saline, Ca caffeine, Co cocaine
Fig. 4 Effect of different doses of W7 on ethanol drinking. Animals
(n=16) were pretreated with W7 (0, 2.5, 5, and 10 mg/kg, i.p.) 30 min
before ethanol (10 %, v/v) exposure. a Cumulative consumption of
ethanol in 2 h. Results are expressed as mean±SEM of grams per
kilogram consumed in 2 h. **p<0.01, significantly different from saline
control group. b Effect of different doses of W7 on saccharine intake.
Animals (n=16–18) were pretreated with W7 (0, 5, and 10 mg/kg, i.p.)
30 min before offering saccharine (0.1 %, w/v) solution. Results are
expressed as mean±SEM of milliliters consumed in 2 h
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measured by a loss of righting reflex paradigm (Baliño et al.
2012; Tarragon et al. 2012). The W7 time-pattern response to
ethanol demonstrated an interaction at short time intervals (15
and 30 min), whereas a recovering effect from the effects of
W7 administration is observed at longer time intervals
(60 min). It is of importance to remark at this point that
CaM blockade seems to have a more prominent role on the
behavioral-stimulating effect of ethanol when compared with
that of other drugs withmotor-stimulating properties. Doses of
W7 that significantly reduced ethanol-induced stimulation did
not alter locomotor activation produced by different
psychostimulants such as caffeine or cocaine, at least at the
doses and times tested in our experiments. Importantly, when
measured during the time course of behavioral testing, this
compound did not modify ethanol blood levels.
Conversely, regarding ethanol intake experiments, we have
employed a daily limited-access model. In our experiments,
control saline animals consumed amounts of ethanol above
2.5 g/kg. At this respect, it has been previously reported that
these ethanol consumption produced a blood–ethanol concen-
tration of approximately 1 mg/ml (≈25 mM), which is able to
produce significant effects on physiology and behavior in
mice (Rhodes et al. 2005; Tarragon et al. 2012). Our results
also showed that pretreatment with the CaM inhibitor W7
dose-dependently reduced voluntary ethanol intake. In agree-
ment with the W7 selectivity effects to ethanol in locomotion,
it is of importance to remark that the suppressant effects of
CaM manipulations on voluntary ethanol intake are probably
not due either to an unspecific inhibition of general ingestive
behavior or alterations in global taste sensation. Doses of W7
that reduced ethanol administration did not significantly
reduce the consumption of sweetened water (Fig. 4b) or total
fluid intake (data not shown).
As we have previously stated, the agent W7 acts as a high-
affinity CaM blocker. In vitro, it has been reported that W7
can interact with other cellular substrates such as the troponin
C and the myosin light-chain kinase (Frampton and Orchard
1992; Hoffman and Sykes 2009). In addition, W7 administra-
tion to cell cultures induced the inhibition of Na(+)–H+cellu-
lar exchange by the voltage-gated sodium channels (Burns
et al. 1991). Despite these W7-unspecific effects, in our stud-
ies we have focused in W7-specific effects on cellular CaM.
The CaM has been described as a cellular Ca2+ sensor. The
binding of Ca2+ alters the conformation of CaM, and the
resulting CaM/Ca2+ complex can interact with target proteins
and modulate their activity (Chin and Means 2000; Solà et al.
1999). Numerous CaM-binding proteins (CaMBP) have been
described in relation to a wide range of cellular functions, from a
structural role to the regulation of gene expression (Lu and
Means 1993). CaM is widely distributed in the mammal brain
(Seto-Ohshima et al. 1983), being of special relevance in sites
involved in neurotransmission (Grab et al. 1980; Sobue et al.
1982; Wood et al. 1980). Different CaMBP proteins have been
described as critical CaM effectors such the AC, Ca2+/ATPase,
cyclic nucleotide phosphodiesterase, and different protein ki-
nases (Klee and Haiech 1980). However, the role of these
CaMBP in mediating the neurobehavioral actions of ethanol
has not been studied in detail yet. Interestingly, different authors
have described the participation of Ca2+-activated CaM cascade
as a major cellular response to ethanol in cultured neural cells
(Conti et al. 2009; Diamond and Gordon 1997). In addition, it
has been shown that this cellular response to ethanol is mediated
trough the direct stimulation of the AC, especially AC1 and
AC8 (Conti et al. 2009; Maas et al. 2005). Given this, one
possible explanation between W7 and the central effects of
ethanol in mice would involve a Ca2+/AC-dependent mecha-
nism. At this point, it is worth mentioning that one key effector
of CaM, the myosin light-chain kinase (MLCK) acts as a critical
mediator of the main regulatory pathways that control the
muscular excitation–contraction coupling. Thus, some of the
behavioral results obtained in this study could be alternatively
explained by an unspecific effect of MLCK inactivation due to a
CaM blockade by W7. However, as we have previously men-
tioned, W7 effects are highly selective for the stimulating and
motivational properties of ethanol.
Interestingly, in agreement with our suggestion, of a
Ca2+/AC-dependent mechanism, several groups have provid-
ed evidence that alterations in the cAMP signaling system
modulate the response to ethanol in vivo. In addition, the
Ca2+/CaM as well as the AC subtypes 1 and 8 have been
considered as a potential locus of interaction between the
cAMP signaling and Ca2+ signal transduction pathways
(Schaefer et al. 2000; Wand et al. 2001; Wong et al. 1999).
Thus, it has been demonstrated that mice lacking of
Fig. 5 Pharmacokinetic response to ethanol in Swiss CD-I mice. Ani-
mals (n=6) were injected withW7 (0 and 5 mg/kg, i.p.), and 30min later,
an ethanol (2.5 g/kg, i.p.) challenge was administered. A sample of 20 μl
of blood was collected from the lateral tail vein at 10, 20, 60, and 120 min
after ethanol injection. Immediately, blood ethanol levels were measured.
Results are expressed as mean ± SEM
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AC1 and/or AC8 responded differently to ethanol adminis-
tration when compared with wild-type animals. Interestingly,
AC8 and AC1 knock-out mice showed a decreased ethanol-
induced locomotor activity and ethanol intake and presented
a variety of deficits in long-term depression and long-term
potentiation (Villacres et al. 1998; Wang et al. 2003). In
contrast to our results, previous published results demon-
strate that mice lacking AC1 and AC8 presented an in-
creased ethanol-induced sedation when compared with con-
trol mice (Maas et al. 2005). As can be observed in Fig. 1b
in our experiments, locomotor depression produced by high
ethanol dose (3.75 g/kg, i.p.) was not affected by the pre-
treatment with W7. At this respect, some strain-dependent
differences in the response to ethanol and/or the neuronal
adaptations carried out by the knock-out mice could explain
these discrepancies. Therefore, convergent support indicates
that there is a dose range of CaM inhibition, which appears
to be able to block the stimulant effects of ethanol in mice
without increasing the depressant/ataxic effects of this
alcohol.
Consistent with our ethanol intake experiments, convergent
support indicates that manipulations of different Ca2+-depen-
dent CaM cascade intermediates were effective in reducing
the ingestive ethanol behavior in mice (Baliño et al. 2012;
Maas et al. 2005; Tarragon et al. 2012). In all cases, tap or
sweetened water drinking was unaffected.
Fig. 6 Immunoblot analysis and quantification of the phosphorylated
PKA substrate. Effects of W7 on the ethanol-induced PKA fingerprint.
Animals were pretreated with W7 (0 and 5 mg/kg, i.p.) 30 min before
ethanol (0 or 2.5 g/kg, i.p.) challenge. Brains were removed and dissected
45 min after an ethanol injection. Protein extracts (20 μg protein/lane)
were analyzed on Western blot with an anti-phosphorylated PKA sub-
strate motif antibody (1:6,000). Top, a representative Western blot of the
PKA fingerprint after ethanol administration. Depicted is the densitomet-
ric analysis performed to quantify the relative intensity of the bands. a
Cortex, b hypothalamus, c hippocampus, and d striatum. Depicted is the
mean±SEM. **p<0.01; *p<0.05, significantly different from its respec-
tive saline control; ##p<0.01; #p<0.05, significantly different from the
saline–ethanol-treated group. S saline, E ethanol
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As stated previously, the activated Ca2+/CaM leads to an
increase of AC activity. These activated AC convert ATP to
cAMP and have been suggested as critical mediators of the
cAMP/PKA cascade in response to ethanol administration
(Conti et al. 2009). Thus, in this work we have investigated
the cellular functional consequences of such ethanol-induced
kinase activation. Similarly to Maas et al.’s (2005), we have
used a subset of phosphorylable substrate consensus motifs as
a PKA-activated fingerprint. These authors demonstrated that
mice treated with ethanol showed an increased intensity of
several bands that represented different phosphorylated PKA-
dependent consensus motif. These bands that were increased
after ethanol treatment in the WT brain were compromised in
the AC1 and AC8 knock-out mice brain. In agreement, our
results showed an increased intensity of the same molecular
weight Western blot bands (Fig. 5) after ethanol administra-
tion in the brain areas of the study. We have focused in four
different brain regional anatomical areas that have been
proved to be involved in this ethanol-induced activation of
PKA. In accordance, immunohistochemical studies have dem-
onstrated an increased activity of the cAMP/PKA signaling
cascade in different brain areas that parallel our Western blot
experiments, such as the prefrontal cortex, the medial and
lateral septum, the basolateral amygdala, the paraventricular
and anterior hypothalamus, hippocampus, dentate gyrus, nu-
cleus accumbens, and the ventral tegmental area (Asyyed et al.
2006; Ostroveanu et al. 2007). Moreover, these neuroanatom-
ical areas have been proposed as specialized reward areas
critical for the behavioral actions elicited by ethanol.
Conversely, when W7 was administered prior to ethanol, the
band densitometry analyses indicate decreased band intensity
when compared with its respective controls as a result of a
decreased Ca2+/CaM-dependent PKA activation by ethanol.
This would indicate that CaM activity is critical to further
activate such cAMP/PKA cascade in response to ethanol.
Ethanol effects on Ca2+ flux and distribution have been
extensively studied in different neuronal cell preparations
(Belia et al. 1995; Davidson et al. 1988; Chan and
Greenberg, 1991). In addition, acute ethanol administration
modulates Ca2+ flux in vitro, and it is generally accepted that
ethanol concentrations (<80 mM) increase intracellular Ca2+
levels (Daniell and Harris 1989; Mironov and Hermann 1996;
Xiao et al. 2005). It has been described that the cytosolic Ca2+
increase can be achieved as the result either of the Ca2+
extracellular influx or its release from internal stores.
Moreover, the cytosolic Ca2+ concentration is controlled by
active Ca2+ sequestration into intracellular stores (endoplas-
mic reticulum and mitochondria) and by Ca2+ binding to
intracellular proteins (Belia et al. 1995; González et al. 2007;
Kelm et al. 2007; Leslie et al. 1990; Salazar et al. 2008).
At this respect, we have previously demonstrated that
extracellular Ca2+ flux as well as intracellular Ca2+ levels
appear to determine the neurobehavioral response to ethanol.
In addition, our group has demonstrated that intracellular Ca2+
homeostasis is critical to the stimulatory effects of ethanol and
ethanol intake in vivo. Animals pretreated with the ER
ryanodine receptor inhibitor dantrolene, presented a decreased
ethanol-induced locomotor activity when systemically admin-
istered and also a decrease in the ethanol ingestive behavior
using a limited-access paradigm (Tarragon et al. 2012).
Moreover, intracellular Ca2+ chelation with BAPTA-AM
was able to modulate selectively the activating effects of
ethanol as well as the ethanol intake (Baliño et al. 2012). In
other words, manipulations affecting Ca2+ flux through
voltage-dependent calcium channels were also effective in
reducing the stimulating effects of ethanol in a dose-
dependent manner when systemically administered (Baliño
et al. 2010). Thus, the behavioral response to acute ethanol
administration appears to share the same molecular mecha-
nism independently as Ca2+ enters from the extracellular side
or its release from the intracellular pools.
Interestingly, recent published data from our laboratory
(Baliño et al. 2013) have demonstrated that there is a different
molecular mechanism implicated in the acute response to
ethanol depending on the source of Ca2+. These experiments
have demonstrated that acute ethanol administration in vivo
promotes an increased activity of the cAMP/PKA cascade.
Manipulations affecting Ca2+ release from the ER appeared to
be critical to further activate the cAMP/PKA cascade, as
animals pretreated with dantrolene did not show an activated
PKA response after ethanol administration. On the contrary,
manipulations of Ca2+ flux through voltage-dependent calci-
um channels did not modify the activation of PKA after
ethanol administration. Thus, the pretreatment with the calci-
um channel blocker diltiazem did not interfere with the
ethanol-induced activation of PKA in mice.
Taking together all these results, we have hypothesized a
linear pattern of Ca2+-dependent events elicited by ethanol,
which primarily involves Ca2+ release through ryanodine recep-
tor to further activate CaM and the cAMP/PKA signaling
pathway, leading to voltage-dependent calcium channels mod-
ulation. This would explain how a different cellular Ca2+ ma-
nipulations share the same functional consequences in a rodent
model. In agreement with our suggestion that involves a linear
sequence of events, it has been shown that Ca2+/CaM facilitates
L-type channel activation through a cAMP/PKA-dependent
mechanism (Marcantoni et al. 2009; Zühlke et al. 1999).
In summary, these data demonstrate a critical role of CaM
in mediating the behavioral response elicited by acute ethanol
administration in mice. Thus, the CaM blockade withW7was
effective in reducing the activating effects produced by etha-
nol. Furthermore, the pretreatment with W7 blocked selec-
tively the ethanol ingestive behavior in mice studied with a
limited-access intake paradigm. The PKA activation by etha-
nol is also prevented in animals pretreated with W7. All these
results with previous literature demonstrate a pivotal role of
Psychopharmacology (2014) 231:4611–4621 4619
Ca2+-dependent events elicited by ethanol that support the
hypothesis of a cAMP/PKA-dependent activation pathway
as a possible mechanism of action of ethanol in the CNS.
Current studies of our laboratory are focused on elucidating
the particular role of such Ca2+-dependent pathways in medi-
ating the behavioral response to ethanol.
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